JG
SRPT icon

Joel Greenblatt’s Sarepta Therapeutics SRPT Stock Holding History

Joel Greenblatt’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-47,552
Closed -$1.03M – 1883
2026
Q1 		$1.03M Sell
47,552
-174,178
-79% -$3.37M ﹤0.01% 1295
2025
Q4 		$4.77M Buy
+221,730
New +$4.67M 0.02% 828
2023
Q2 		– Sell
-2,847
Closed -$392K – 1419
2023
Q1 		$392K Sell
2,847
-1,405
-33% -$182K 0.01% 1042
2022
Q4 		$551K Sell
4,252
-9,611
-69% -$1.11M 0.02% 866
2022
Q3 		$1.53M Buy
13,863
+8,615
+164% +$868K 0.05% 490
2022
Q2 		$393K Sell
5,248
-7,192
-58% -$529K 0.01% 863
2022
Q1 		$972K Buy
+12,440
New +$953K 0.03% 568
2020
Q1 		– Sell
-1,601
Closed -$207K – 1201
2019
Q4 		$207K Buy
+1,601
New +$162K ﹤0.01% 1038
2019
Q3 		– Sell
-3,948
Closed -$600K – 1210
2019
Q2 		$600K Sell
3,948
-71
-2% -$8.63K 0.01% 748
2019
Q1 		$479K Sell
4,019
-319
-7% -$41K 0.01% 859
2018
Q4 		$473K Sell
4,338
-8,614
-67% -$1.08M 0.01% 778
2018
Q3 		$2.09M Buy
12,952
+3,028
+31% +$414K 0.03% 488
2018
Q2 		$1.31M Buy
+9,924
New +$936K 0.02% 543
2017
Q4 		– Sell
-9,268
Closed -$420K – 1054
2017
Q3 		$420K Buy
+9,268
New +$370K 0.01% 729

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Joel Greenblatt's SRPT Position: Q2 2026 in Review

Joel Greenblatt sold out of Sarepta Therapeutics (SRPT) in Q2 2026, closing a stake of 47,552 shares — an estimated $1.03M sold.

Joel Greenblatt first reported a position in SRPT in Q3 2017 and held it in 14 quarters. The position peaked at $4.77M in Q4 2025. 320 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

  • Joel Greenblatt reported no remaining Sarepta Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Joel Greenblatt sold 47,552 Sarepta Therapeutics shares in Q2 2026, an estimated $1.03M.
  • Joel Greenblatt first reported a position in Sarepta Therapeutics in Q3 2017 and held it in 14 quarters.
  • Joel Greenblatt's Sarepta Therapeutics position peaked at $4.77M in Q4 2025.
  • 320 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on Gotham Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.